Literature DB >> 7050289

Modulation of human lymphocyte function by C3a and C3a(70-77).

D G Payan, D E Trentham, E J Goetzl.   

Abstract

Human C3a and the synthetic octapeptide C3a (70-77), which retains the activities of an anaphylatoxin, inhibit in a concentration-dependent manner the generation of leukocyte inhibitory factor (LIF) activity by human mononuclear leukocytes and T lymphocytes cultured with the mitogens phytohemagglutinin (PHA) or concanavalin A (Con A) or the antigen streptokinase-streptodornase (SK-SD). The generation of LIF activity was inhibited by 50% by 10(-8) M C3a or C3a(70-77) with PHA or Con A as the stimulus, whereas a more than 10-fold higher concentration of C3a(70-77) than C3a was required to achieve the same level of suppression with SK-SD as the stimulus. Similar concentrations of C3a(70-77) inhibited to the same extent the migration of T lymphocytes stimulated by alpha-thioglycerol of Con A. Neither C3a nor C3a(70-77) altered significantly the uptake of [3H]thymidine by human mononuclear cells exposed to PHA, Con A, or SK-SD. The capacity of C3a(70-77)-Sepharose,m but not Sepharose alone, to adsorb or inactivate mononuclear leukocytes required for the generation of LIF activity established a direct interaction. Analysis of the lymphocytes in the effluent from C3a(70-77)-Sepharose columns, using monoclonal antibodies to surface antigens, showed a selective depletion of the helper/inducer population of lymphocytes. C3a might represent an important mediator of the functionally selective regulation of human T lymphocyte activities by the complement system.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7050289      PMCID: PMC2186792          DOI: 10.1084/jem.156.3.756

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

Review 1.  Anaphylatoxins: C3a and C5a.

Authors:  T E Hugli; H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1978       Impact factor: 3.543

2.  Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Expression and modulation of C3 receptors during early T-cell ontogeny.

Authors:  A Shore; H M Dosch; E W Gelfand
Journal:  Cell Immunol       Date:  1979-06       Impact factor: 4.868

4.  Stimulation of human T-lymphocyte chemokinesis by arachidonic acid.

Authors:  J McCarty; E J Goetzl
Journal:  Cell Immunol       Date:  1979-03-01       Impact factor: 4.868

Review 5.  Role of complement in the induction of immunological responses.

Authors:  M B Pepys
Journal:  Transplant Rev       Date:  1976

6.  Purification and partial characterization of human and porcine C3a anaphylatoxin.

Authors:  T E Hugli; E H Vallota; H J Müller-Eberhard
Journal:  J Biol Chem       Date:  1975-02-25       Impact factor: 5.157

7.  Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.

Authors:  E J Goetzl; R E Rocklin
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

8.  Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.

Authors:  T E Hugli; B W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

9.  A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.

Authors:  C Bianco; R Patrick; V Nussenzweig
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

10.  Receptors for complement of leukocytes.

Authors:  W H Lay; V Nussenzweig
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  9 in total

1.  Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid.

Authors:  D G Payan; M Y Wong; T Chernov-Rogan; F H Valone; W C Pickett; V A Blake; W M Gold; E J Goetzl
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

2.  Evidence for in vivo degradation of C3a anaphylatoxin by mast cell chymase. I. Nonspecific activation of rat peritoneal mast cells by C3ades Arg.

Authors:  T Kajita; T E Hugli
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

3.  Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis.

Authors:  T Tsuruta; T Yamamoto; S Matsubara; S Nagasawa; S Tanase; J Tanaka; K Takagi; T Kambara
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

Review 4.  The chemistry and biology of complement receptors.

Authors:  R D Schreiber
Journal:  Springer Semin Immunopathol       Date:  1984

Review 5.  The role of complement in the induction and regulation of immune responses.

Authors:  T G Egwang; A D Befus
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

Review 6.  Regulation of immune response by components of the complement cascade and their activated fragments.

Authors:  W O Weigle; M G Goodman; E L Morgan; T E Hugli
Journal:  Springer Semin Immunopathol       Date:  1983

7.  Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4.

Authors:  D G Payan; A Missirian-Bastian; E J Goetzl
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.

Authors:  R Huey; C M Bloor; M S Kawahara; T E Hugli
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

9.  Substance P recognition by a subset of human T lymphocytes.

Authors:  D G Payan; D R Brewster; A Missirian-Bastian; E J Goetzl
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.